UCLA researchers in the Division of Plastic and Reconstructive Surgery, have developed an innovative biocompatible composite material that drastically improves bone regeneration after reconstructive surgery.
BACKGROUND: Cranioplasty is a type of craniofacial reconstructive surgery that is particularly challenging due to the need to protect the underlying cerebral tissue while the cranial bone regenerates. Current cranioplasty materials either involve resecting the patient’s own bone for grafting, which is limited in quantity and not without significant complications, or using synthetic alloplastic materials, which are less biocompatible and may result in the need for removal due to infection. Thus, there is substantial interest in developing more biocompatible scaffolding materials that can enhance natural bone formation. Commercially available biocompatible scaffolds currently utilize collagen and hydrogel materials, but many require supplementation with stem cells or growth factors to stimulate natural bone growth. While effective, these approaches can increase cost, prolong production time, and introduce additional safety concerns. Ideally, these biocompatible scaffolds should be fixed to the resident bone using a biodegradable material with similar mechanical properties to native bone. Currently, there is an unmet clinical need for biocompatible materials that can protect the sensitive underlying tissue, promote bone regeneration, and biodegrade as they are replaced by bone that is structurally and functionally healthy.
INNOVATION: Researchers at UCLA led by Dr. Justine Lee have developed a novel composite material that improves the regenerative capacity of native bone in cranial defects, adequately protects the underlying brain tissues, and biodegrades over a time frame that supports replacement by bone with favorable mechanical properties. The research team previously demonstrated that nanoparticulate mineralized collagen glycosaminoglycan (MC-GAG) scaffolds stimulate cranial bone growth without requiring stem cell or growth factor supplementation. Furthermore, poly-D-L-lactide (PDLLA) is commonly used for fixation because its strength and stiffness are similar to native bone and it can biodegrade as new bone forms. The research team has created a novel composite material by combining MC-GAG with a clinically available resorbable PDLLA implant that can successfully repair cranial defects by stimulating bone tissue deposition in a manner closely reflects the thickness, strength, and stiffness of the resident native bone. This innovative material provides a stem cell- and growth factor-free option that may reduce both cost and production time, while improving biocompatibility and reducing unintended side effects.
POTENTIAL APPLICATIONS:
ADVANTAGES:
DEVELOPMENT-TO-DATE: This technology has been shown to be successful in significantly improving bone regeneration in a rabbit model of cranial defect.
Related Papers (from the inventors only):
Meiwand Bedar, Xiaoyan Ren, Wei Chen, Youngnam Kang, Shahrzad Moghadam, Kelly X. Huang, Kaavian Shariati, Brendan A.C. Harley, Justine C. Lee. 2025. Resorbable Poly-(D,L)-Lactide Anchorage of Nanoparticulate Mineralized Collagen Materials Maximizes In Vivo Skull Regeneration. bioRxiv doi: https://doi.org/10.1101/2025.07.06.663409
Keywords: Bone regeneration, cranioplasty, craniofacial reconstruction, collagen scaffold, cranial defect, MC-CAG, PDLLA, resorbable implant, regenerative medicine, bone repair